INVO Bioscience (NASDAQ:INVO) Stock Price Down 0.2% – Should You Sell?

INVO Bioscience, Inc. (NASDAQ:INVOGet Free Report) shares dropped 0.2% on Thursday . The stock traded as low as $0.45 and last traded at $0.46. Approximately 21,488 shares changed hands during trading, a decline of 99% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.46.

INVO Bioscience Stock Down 5.4 %

The stock’s 50 day moving average is $0.70 and its two-hundred day moving average is $0.78.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. bought a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVOFree Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned approximately 2.64% of INVO Bioscience as of its most recent SEC filing. Institutional investors own 12.02% of the company’s stock.

About INVO Bioscience

(Get Free Report)

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.

Recommended Stories

Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.